|
On (b)(6) 2023 it was reported by an arthrex subsidiary employee via email that an ar-8928bc-cp biocomposite achilles speedbridge implant delivery was used during an achilles tendon repair procedure on (b)(6) 2017.After the surgery, the patient complained of pain due to the protrusion of the anchor.A revision surgery was performed to remove the anchor on (b)(6) 2017.The patient recovered well after the revision surgery.No further information has been reported.Additional information received on (b)(6) 2023: this information was obtained from case data included in a summary of an academic conference presentation.Per the arthrex subsidiary employee, the sales representative does not know the exact date of the revision surgery, but it is estimated to be on (b)(6) 2017.No further information could be obtained regarding this these surgeries.
|
|
Additional information: g3, h3, h6.Based on the information provided, which may include the device (if available and returned), pictures, videos, event descriptions, and any additional information from the field, arthrex was able to conclude the most likely cause.The most likely cause of the reported failure is patient specific event, specifically, an allergic reaction to the implanted device.The complaint allegation was not confirmed.The device was not received for evaluation, and no evidence of the failure was provided.
|